
Retatrutide
Investigational GIP / GLP-1 / Glucagon Receptor Agonist
Overview
Retatrutide is an investigational synthetic peptide studied for activity at the GIP, GLP-1, and glucagon receptors.
Current research examines receptor signaling, glucose homeostasis, metabolic pathways, energy balance, and related physiological mechanisms.
Research Focus
GIP, GLP-1, and glucagon receptor signaling
Glucose and metabolic pathway research
Energy-balance mechanisms
Substrate utilization
Metabolic signaling
Product Specifications
Form: Lyophilized peptide
In-Stock Strengths: 10 mg, 20 mg, 30 mg
Special-Order Strengths: 5 mg, 15 mg, 40 mg, 50 mg, 60 mg
Special Orders
Additional strengths may be available by special order. Availability, pricing, and lead times are subject to confirmation.
Storage
Store refrigerated at 2–8°C, unless otherwise specified.
Research Use Only
For laboratory and research applications only. Not intended for human or veterinary use, consumption, diagnosis, treatment, or clinical application.
